These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3757627)

  • 1. [Fibrinogen degradation products in human CSF: a preliminary clinical study].
    Li YP
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1986 Jun; 19(3):142-5. PubMed ID: 3757627
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significance of fibrin fibrinogen degradation products in the cerebrospinal fluid in the neonatal period].
    Dalens B; Bezou MJ; Coulet M; Raynaud EJ
    Ann Pediatr (Paris); 1983 Jan; 30(1):59-62. PubMed ID: 6830109
    [No Abstract]   [Full Text] [Related]  

  • 3. [FDP levels in the cerebrospinal fluid are elevated in patients with meningitis].
    Okamoto S; Takahashi H; Minoura K; Fujita N; Yoshimura M
    Rinsho Byori; 1991 Jun; 39(6):651-5. PubMed ID: 1880942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fibrinogen degradation products in the cerebrospinal fluid in central nervous system diseases].
    Kolanowska H; Solecka B
    Pol Przegl Chir; 1980 Aug; 52(8):729-34. PubMed ID: 7433284
    [No Abstract]   [Full Text] [Related]  

  • 5. [Determination of fibrin-fibrinogen degradation products (FFDP) in the diagnosis of meningitis in children].
    Myśliwiec B
    Pediatr Pol; 1980 Apr; 55(4):421-6. PubMed ID: 7413304
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunoglobulins A, M and G, fibrinogen degradation products (FFDP) and alkaline phosphatase activity in the cerebrospinal fluid in differential diagnosis of meningitis in children].
    Rudobielska M; Szafrańska M; Zoch-Zwierz W; Myśliwiec B
    Pol Tyg Lek; 1980 Aug; 35(34):1293-5. PubMed ID: 7443556
    [No Abstract]   [Full Text] [Related]  

  • 7. [Fibrin(ogen degradation product concentration (SFP) as a diagnostic parameter for the differentiation of artifical and essential blood in cerebrospinal fluid].
    Hindersin P; Heidrich R
    Psychiatr Neurol Med Psychol (Leipz); 1978 Jan; 30(1):36-9. PubMed ID: 643973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fibrinogen degradation products in the cerebrospinal fluid of children with lymphoblastic leukemia].
    Borkowski W; Kolanowska H; Depowska T; Kaczor Z
    Pediatr Pol; 1981 Sep; 56(9):1017-20. PubMed ID: 6948264
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fibrinogen degradation products (FDP) in purulent cerebrospinal meningitis in children].
    Myśliwiec B
    Pol Tyg Lek; 1978 Jul; 33(31):1213-5. PubMed ID: 693393
    [No Abstract]   [Full Text] [Related]  

  • 10. [Plasminogen concentration in the cerebrospinal fluid of patients with various neurological diseases (author's transl)].
    Maruyama I; Igata A
    Rinsho Shinkeigaku; 1979 Aug; 19(8):481-5. PubMed ID: 498662
    [No Abstract]   [Full Text] [Related]  

  • 11. Rapid differential diagnosis between subarachnoid hemorrhage and traumatic lumbar puncture by D-dimer assay.
    Juliá-Sanchis ML; Estela-Burriel PL; Lirón-Hernández FJ; Guerrero-Espejo A
    Clin Chem; 2007 May; 53(5):993. PubMed ID: 17468411
    [No Abstract]   [Full Text] [Related]  

  • 12. Fibrin-fibrinogen degradation products in cerebrospinal fluid.
    Brueton MJ; Breeze GR; Stuart J
    J Clin Pathol; 1976 Apr; 29(4):341-4. PubMed ID: 932226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoelectric focusing (IF) of cerebrospinal fluid (CSF) proteins: II) preliminary results in brain atrophies of various etiologies.
    Livrea P; Federico F; Simone I; Zimatore G; Turso L; Negro C
    Boll Soc Ital Biol Sper; 1977 Apr; 53(7):511-7. PubMed ID: 911508
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fibrin-fibrinogen degradation products in cerebrospinal fluid of patients with meningococcal infections (author's transl)].
    Bajo R; Vaca R; Elduayen R; Zarallo L; Cardesa JJ; Pérez-Miranda M
    Med Clin (Barc); 1980 Nov; 75(8):338-41. PubMed ID: 7442335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Signification of fibrinogen degradation (FDP) product in CSF during the neonatal period (author's transl)].
    Dalens B; Bezou MJ; Coulet M; Raynaud EJ
    Pathol Biol (Paris); 1981 Dec; 29(10):605-8. PubMed ID: 7041056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen-fibrin degradation products in renal disorders.
    Dube B; Srivastava PK; Padmanabhan R; Dube RK
    Indian J Pathol Microbiol; 1979 Oct; 22(4):313-22. PubMed ID: 548482
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical value of determining fibrin and fibrinogen degradation products in kidney diseases].
    Belitskaia GA; Ena IaM; Varetskaia TV; Shevchenko LI
    Klin Med (Mosk); 1976 Mar; 54(3):96-102. PubMed ID: 966670
    [No Abstract]   [Full Text] [Related]  

  • 18. [Method of radial immunodiffusion by Mancini for determination of fibrin fibrinogen degradation products].
    Mikhaĭlova ND; Guseĭnov ChS; Likhacheva ZI; Gorelova AM
    Lab Delo; 1978; (8):490-3. PubMed ID: 80505
    [No Abstract]   [Full Text] [Related]  

  • 19. rHuEPO increases urinary excretion of fibrin degradation products in haemodialysed patients.
    Gareau R; Gagnon MG; Ayotte C; Chénard C; Brisson GR
    Thromb Haemost; 1993 Aug; 70(2):373-4. PubMed ID: 8236152
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical and immunoelectrophoretic study of cerebrospinal fluid proteins].
    De Zanche L; Tavolato B
    Acta Neurol (Napoli); 1967; 22(4):555-72. PubMed ID: 4178507
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.